Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients

BACKGROUND/AIM: TP53 mutation is recognized as a negative prognostic factor for patients with diffuse large B-cell lymphoma (DLBCL). Here, we present the characteristics of TP53(mut) DLBCL patients following investigation of the effect of a treatment approach on survival of TP53(mut) DLBCL patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yan, Jiang, Shiyu, Liu, Peng, Yang, Jianliang, Yang, Sheng, He, Xiaohui, Zhou, Shengyu, Gui, Lin, Lin, Jing, Du, Xinhua, Yi, Yuting, Sun, Yan, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666999/
https://www.ncbi.nlm.nih.gov/pubmed/33204162
http://dx.doi.org/10.2147/CMAR.S269624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666999/
https://www.ncbi.nlm.nih.gov/pubmed/33204162
http://dx.doi.org/10.2147/CMAR.S269624

Ejemplares similares